Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.350
-0.040 (-2.88%)
At close: Dec 5, 2025, 4:00 PM EST
1.369
+0.019 (1.42%)
After-hours: Dec 5, 2025, 7:59 PM EST
Aptevo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -26.47 | -24.13 | -17.41 | 8.03 | -28.46 | -17.75 | |
| Depreciation & Amortization | 0.23 | 0.35 | 0.57 | 0.9 | 1.14 | 1.31 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0.05 | 0 | - | |
| Stock-Based Compensation | 0.02 | 1.07 | 2.19 | 1.8 | 1.64 | 1.26 | |
| Other Operating Activities | - | - | 0.01 | -33.94 | 6.64 | 2.52 | |
| Change in Accounts Receivable | - | - | 2.5 | 1.16 | -1.3 | -2.37 | |
| Change in Accounts Payable | -0.27 | -1.02 | 0.52 | -0.39 | -1.92 | -0.7 | |
| Change in Other Net Operating Assets | 0.37 | -0.06 | -0.11 | 1.37 | 0.56 | 0.67 | |
| Operating Cash Flow | -26.12 | -23.79 | -11.73 | -21.02 | -21.68 | -29.32 | |
| Capital Expenditures | - | - | - | -0.03 | -0.71 | -0.09 | |
| Other Investing Activities | - | - | - | - | - | 28.12 | |
| Investing Cash Flow | - | - | - | -0.03 | -0.71 | 28.03 | |
| Long-Term Debt Issued | - | - | - | - | - | 24.73 | |
| Long-Term Debt Repaid | - | - | -3.47 | -12.27 | -10.55 | -22.1 | |
| Net Debt Issued (Repaid) | - | - | -3.47 | -12.27 | -10.55 | 2.63 | |
| Issuance of Common Stock | 39.42 | 15.6 | 9.48 | 6.93 | 11.44 | 21.26 | |
| Repurchase of Common Stock | - | -0 | -0.01 | -0 | - | -0.01 | |
| Other Financing Activities | - | -0 | - | 2.72 | 25.27 | - | |
| Financing Cash Flow | 39.42 | 15.6 | 6 | -2.62 | 26.16 | 23.87 | |
| Net Cash Flow | 13.31 | -8.19 | -5.73 | -23.67 | 3.77 | 22.59 | |
| Free Cash Flow | -26.12 | -23.79 | -11.73 | -21.05 | -22.39 | -29.41 | |
| Free Cash Flow Margin | - | - | - | -676.01% | -182.17% | -682.43% | |
| Free Cash Flow Per Share | -18.24 | -1722.68 | - | - | - | - | |
| Levered Free Cash Flow | -16.13 | -15.52 | -11.7 | -29.32 | 2.01 | -13.29 | |
| Unlevered Free Cash Flow | -16.13 | -15.52 | -11.7 | -29.32 | 2.01 | -13.29 | |
| Change in Working Capital | 0.11 | -1.08 | 2.91 | 2.14 | -2.66 | -2.41 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.